Last updated 3 years ago

Disruptability [+]

Species Disruptability Reference Submitter
P. yoelii yoelii 17X
Possible
RMgm-4568 Imported from RMgmDB
P. berghei ANKA
Possible
RMgm-592 Imported from RMgmDB
P. berghei ANKA
Possible
RMgm-44 Imported from RMgmDB
P. berghei ANKA
Possible
RMgm-41 Imported from RMgmDB
P. berghei ANKA
Possible
RMgm-40 Imported from RMgmDB
P. berghei ANKA
Possible
PlasmoGEM (Barseq) PlasmoGEM
P. falciparum 3D7
Possible
18958160 Theo Sanderson, Wellcome Trust Sanger Institute
P. falciparum 3D7
Refractory
USF piggyBac screen (Insert. mut.) USF PiggyBac Screen

Mutant phenotypes [+]

Species Stage Phenotype Reference Submitter
P. yoelii yoelii 17X Asexual
No difference
RMgm-4568 Imported from RMgmDB
P. yoelii yoelii 17X Gametocyte
No difference
RMgm-4568 Imported from RMgmDB
P. berghei ANKA Asexual
No difference
RMgm-592 Imported from RMgmDB
P. berghei ANKA Asexual
No difference
RMgm-44 Imported from RMgmDB
P. berghei ANKA Asexual
No difference
RMgm-41 Imported from RMgmDB
P. berghei ANKA Asexual
No difference
RMgm-40 Imported from RMgmDB
P. berghei ANKA Asexual
No difference
PlasmoGEM (Barseq) PlasmoGEM
P. falciparum 3D7 Asexual
No difference
18958160 Theo Sanderson, Wellcome Trust Sanger Institute
P. berghei ANKA Gametocyte
No difference
RMgm-592 Imported from RMgmDB
P. berghei ANKA Gametocyte
No difference
RMgm-44 Imported from RMgmDB
P. berghei ANKA Gametocyte
No difference
RMgm-41 Imported from RMgmDB
P. berghei ANKA Gametocyte
No difference
RMgm-40 Imported from RMgmDB
P. falciparum 3D7 Gametocyte
No difference
18958160 Theo Sanderson, Wellcome Trust Sanger Institute
P. berghei ANKA Ookinete
No difference
RMgm-592 Imported from RMgmDB
P. berghei ANKA Ookinete
No difference
RMgm-44 Imported from RMgmDB
P. berghei ANKA Ookinete
No difference
RMgm-41 Imported from RMgmDB
P. berghei ANKA Ookinete
No difference
RMgm-40 Imported from RMgmDB
P. falciparum 3D7 Ookinete
No difference
18958160 Theo Sanderson, Wellcome Trust Sanger Institute
P. berghei ANKA Oocyst
No difference
RMgm-592 Imported from RMgmDB
P. berghei ANKA Oocyst
No difference
RMgm-44 Imported from RMgmDB
P. berghei ANKA Oocyst
No difference
RMgm-41 Imported from RMgmDB
P. berghei ANKA Oocyst
No difference
RMgm-40 Imported from RMgmDB
P. falciparum 3D7 Oocyst
No difference
18958160 Theo Sanderson, Wellcome Trust Sanger Institute
P. berghei ANKA Sporozoite
No difference
RMgm-592 Imported from RMgmDB
P. berghei ANKA Sporozoite
No difference
RMgm-44 Imported from RMgmDB
P. berghei ANKA Sporozoite
No difference
RMgm-41 Imported from RMgmDB
P. berghei ANKA Sporozoite
No difference
RMgm-40 Imported from RMgmDB
P. falciparum 3D7 Sporozoite
No difference
18958160 Theo Sanderson, Wellcome Trust Sanger Institute
P. berghei ANKA Liver
Difference from wild-type
RMgm-592
Based on phenotype analyses of mutants RMgm-40 and RMgm-44 that lack expression of P36p/P52 (In this study these parasites have been used to analyse sporozoites in the skin of mice):Gliding motility, hepatocyte traversal and hepatocyte invasion in vitro (HepG2) of mutant sporozoites is similar to wild type sporozoites. Liver stage development is strongly impaired and parasites do not develop into the schizont stage and most invaded parasites cannot be detected anymore at 24 hours after infection. Inside the hepatocytes the formation of a parasitophourous vacuole is not detected at 15 and 24h after infections as shown by staining with antibodies against the parasithophorous vacuole membrane protein PbExp1 (HEP17).Infection of mice (C57BL/6) by bite of infected mosquitoes did not result in blood stage infection. Only intravenous inoculation of very high numbers of sporozoites (50.000) resulted in blood stage infection in a very low percentage of the mice.
Imported from RMgmDB
P. berghei ANKA Liver
Difference from wild-type
RMgm-44
Gliding motility is similar to wild type sporozoites. Hepatocyte traversal activity in vitro (HepG2) was higher than of wild type sporooites (~5 times higher). Hepatocyte invasion of mutant sporozoites was significantly decreased (~8% of that of wildtype). Liver stage development is strongly impaired and parasites do not develop into the schizont stage. Infectivity of sporozoites as measured by infection of rats (Wistar) by intravenous inoculation of sporozoites was strongly reduced (3000 times compared to wildtype).
Imported from RMgmDB
P. berghei ANKA Liver
Difference from wild-type
RMgm-41
Gliding motility, hepatocyte traversal and hepatocyte invasion in vitro (HepG2) of mutant sporozoites is similar to wild type sporozoites. Liver stage development is strongly impaired and parasites do not develop into the schizont stage and most invaded parasites cannot be detected anymore at 24 hours after infection. Inside the hepatocytes the formation of a parasitophourous vacuole is not detected at 15 and 24h after infections as shown by staining with antibodies against the parasithophorous vacuole membrane protein PbExp1 (HEP17).Infection of mice (C57BL/6) by bite of infected mosquitoes did not result in blood stage infection. Only intraveneous inoculation of very high numbers of sporozoites (50.000) resulted in blood stage infection in a very low percentage of the mice.
Imported from RMgmDB
P. berghei ANKA Liver
Difference from wild-type
RMgm-40
Gliding motility, hepatocyte traversal and hepatocyte invasion in vitro (HepG2) of mutant sporozoites is similar to wild type sporozoites. Liver stage development is strongly impaired and parasites do not develop into the schizont stage and most invaded parasites cannot be detected anymore at 24 hours after infection. Inside the hepatocytes the formation of a parasitophourous vacuole is not detected at 15 and 24h after infections as shown by staining with antibodies against the parasithophorous vacuole membrane protein PbExp1 (HEP17).Infection of mice (C57BL/6) by bite of infected mosquitoes did not result in blood stage infection. Only intraveneous inoculation of very high numbers of sporozoites (50.000) resulted in blood stage infection in a very low percentage of the mice.
Imported from RMgmDB
P. falciparum 3D7 Liver
Attenuated
18958160 Theo Sanderson, Wellcome Trust Sanger Institute

More information